Aurobindo Pharma Receives US FDA Form 483 with 9 Observations

⚠️

has received a Form 483 with 9 observations from the U.S. Food and Drug Administration for its Eugia Pharma Unit-II facility. The inspection outcome has been classified as “Official Action Indicated” (OAI) following the regulatory review.